Medicine for Osteoarthritis Pain Market Report

China Medicine for Osteoarthritis Pain Industry Market Research Report 2023-2029

  • POSTDATE：Aug 31, 2023
  • PAGES：135
  • REPORT CODE：GMM1768030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Medicine for Osteoarthritis Pain industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Tide Pharmaceutical

    • Daiichi Sankyo

    • Eli Lilly

    • Mylan

    • Hengrui Pharmaceutical

    • Astellas Pharma

    • Pfizer

    • Iroko Pharmaceuticals

    • GlaxoSmithKline

    • Novartis

    • Abiogen Pharma

    • Abbott

    • TEVA

    • Sanofi

    • Horizon Pharma

    By Type:

    • External

    • Oral

    • Injection

    By Application:

    • Medical Care

    • Personal Care

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Medicine for Osteoarthritis Pain Market Overview 2018-2029

    • 1.1 China Medicine for Osteoarthritis Pain Industry Development Overview

    • 1.2 China Medicine for Osteoarthritis Pain Industry Development History

    • 1.3 China Medicine for Osteoarthritis Pain Industry Market Size (2018-2029)

    • 1.4 China Medicine for Osteoarthritis Pain Market Analysis by Type from Production Side

      • 1.4.1 China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of External (2018-2029)

      • 1.4.2 China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of Oral (2018-2029)

      • 1.4.3 China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • 1.5 China Medicine for Osteoarthritis Pain Market Analysis by Application from Consumption End

      • 1.5.1 China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate of Medical Care (2018-2029)

      • 1.5.2 China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate of Personal Care (2018-2029)

    • 1.6 China Medicine for Osteoarthritis Pain Market Analysis by Region

      • 1.6.1 North China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    Chapter 2 China Medicine for Osteoarthritis Pain Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Medicine for Osteoarthritis Pain Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Medicine for Osteoarthritis Pain Market Status and Competition Analysis in 2023

      • 2.2.3 China Medicine for Osteoarthritis Pain Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Medicine for Osteoarthritis Pain Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Medicine for Osteoarthritis Pain Industry Development

    Chapter 3 Medicine for Osteoarthritis PainIndustry Chain Analysis

    • 3.1 Medicine for Osteoarthritis Pain Industry Chain

    • 3.2 Medicine for Osteoarthritis Pain Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Medicine for Osteoarthritis Pain Market

    • 3.3 Medicine for Osteoarthritis Pain Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Medicine for Osteoarthritis Pain Market

    Chapter 4 China Medicine for Osteoarthritis Pain Market, by Type

    • 4.1 China Medicine for Osteoarthritis Pain Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Medicine for Osteoarthritis Pain Total Production Volume and Growth Rate from Production Side

    • 4.5 China Medicine for Osteoarthritis Pain Production Volume and Growth Rate, by Type

      • 4.5.1 China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of External

      • 4.5.2 China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of Oral

      • 4.5.3 China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of Injection

    Chapter 5 China Medicine for Osteoarthritis Pain Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Medicine for Osteoarthritis Pain Total Market Size and Growth Rate from Consumption End

    • 5.5 China Medicine for Osteoarthritis Pain Market Size and Growth Rate, by Application

      • 5.5.1 China Medicine for Osteoarthritis Pain Market Size and Growth Rate of Medical Care

      • 5.5.2 China Medicine for Osteoarthritis Pain Market Size and Growth Rate of Personal Care

    Chapter 6 China Medicine for Osteoarthritis Pain Market, by Region

    • 6.1 China Medicine for Osteoarthritis Pain Production Volume and Production Value, by Region

    • 6.2 China Medicine for Osteoarthritis Pain Sales Volume and Sales Value, by Region

    Chapter 7 North China Medicine for Osteoarthritis Pain Market Analysis

    • 7.1 North China Medicine for Osteoarthritis Pain Market, by Type

    • 7.2 North China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 8 Central China Medicine for Osteoarthritis Pain Market Analysis

    • 8.1 Central China Medicine for Osteoarthritis Pain Market, by Type

    • 8.2 Central China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 9 South China Medicine for Osteoarthritis Pain Market Analysis

    • 9.1 South China Medicine for Osteoarthritis Pain Market, by Type

    • 9.2 South China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 10 East China Medicine for Osteoarthritis Pain Market Analysis

    • 10.1 East China Medicine for Osteoarthritis Pain Market, by Type

    • 10.2 East China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 11 Northeast China Medicine for Osteoarthritis Pain Market Analysis

    • 11.1 Northeast China Medicine for Osteoarthritis Pain Market, by Type

    • 11.2 Northeast China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 12 Southwest China Medicine for Osteoarthritis Pain Market Analysis

    • 12.1 Southwest China Medicine for Osteoarthritis Pain Market, by Type

    • 12.2 Southwest China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 13 Northwest China Medicine for Osteoarthritis Pain Market Analysis

    • 13.1 Northwest China Medicine for Osteoarthritis Pain Market, by Type

    • 13.2 Northwest China Medicine for Osteoarthritis Pain Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Tide Pharmaceutical

        • 14.1.1 Tide Pharmaceutical Company Profile

        • 14.1.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Daiichi Sankyo

        • 14.2.1 Daiichi Sankyo Company Profile

        • 14.2.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly

        • 14.3.1 Eli Lilly Company Profile

        • 14.3.2 Eli Lilly Medicine for Osteoarthritis Pain Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Mylan

        • 14.4.1 Mylan Company Profile

        • 14.4.2 Mylan Medicine for Osteoarthritis Pain Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hengrui Pharmaceutical

        • 14.5.1 Hengrui Pharmaceutical Company Profile

        • 14.5.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Astellas Pharma

        • 14.6.1 Astellas Pharma Company Profile

        • 14.6.2 Astellas Pharma Medicine for Osteoarthritis Pain Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Medicine for Osteoarthritis Pain Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Iroko Pharmaceuticals

        • 14.8.1 Iroko Pharmaceuticals Company Profile

        • 14.8.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GlaxoSmithKline

        • 14.9.1 GlaxoSmithKline Company Profile

        • 14.9.2 GlaxoSmithKline Medicine for Osteoarthritis Pain Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Novartis

        • 14.10.1 Novartis Company Profile

        • 14.10.2 Novartis Medicine for Osteoarthritis Pain Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Abiogen Pharma

        • 14.11.1 Abiogen Pharma Company Profile

        • 14.11.2 Abiogen Pharma Medicine for Osteoarthritis Pain Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Abbott

        • 14.12.1 Abbott Company Profile

        • 14.12.2 Abbott Medicine for Osteoarthritis Pain Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 TEVA

        • 14.13.1 TEVA Company Profile

        • 14.13.2 TEVA Medicine for Osteoarthritis Pain Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Sanofi

        • 14.14.1 Sanofi Company Profile

        • 14.14.2 Sanofi Medicine for Osteoarthritis Pain Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Horizon Pharma

        • 14.15.1 Horizon Pharma Company Profile

        • 14.15.2 Horizon Pharma Medicine for Osteoarthritis Pain Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Medicine for Osteoarthritis Pain Industry Research Conclusions

    • 15.2 Medicine for Osteoarthritis Pain Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Medicine for Osteoarthritis Pain Industry Market Size (2018-2029)

    • Figure China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of External (2018-2029)

    • Figure China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Medicine for Osteoarthritis Pain Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate of Medical Care (2018-2029)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume, Sales Value and Growth Rate of Personal Care (2018-2029)

    • Figure North China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure Central China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure South China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure East China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Medicine for Osteoarthritis Pain Market Size and Growth Rate from 2018-2029

    • Figure Medicine for Osteoarthritis Pain Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Medicine for Osteoarthritis Pain Market Share by Type in 2018

    • Figure China Medicine for Osteoarthritis Pain Market Share by Type in 2023

    • Figure China Medicine for Osteoarthritis Pain Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of External (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Market Share by Application in 2018

    • Figure China Medicine for Osteoarthritis Pain Market Share by Application in 2023

    • Figure China Medicine for Osteoarthritis Pain Total Market Size and Growth Rate from Consumption End

    • Figure China Medicine for Osteoarthritis Pain Market Size and Growth Rate of Medical Care (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Market Size and Growth Rate of Personal Care (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Production Volume by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Production Volume Share by Region (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Production Volume Share by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Production Value by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Production Value Share by Region (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Production Value Share by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Sales Volume by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Sales Volume Share by Region (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Sales Volume Share by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Sales Value by Region (2018-2023)

    • Table China Medicine for Osteoarthritis Pain Sales Value Share by Region (2018-2023)

    • Figure China Medicine for Osteoarthritis Pain Sales Value Share by Region (2018-2023)

    • Table North China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table North China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure North China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table North China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table North China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure North China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table Central China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table Central China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure Central China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table Central China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table Central China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure Central China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table South China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table South China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure South China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table South China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table South China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure South China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table East China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table East China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure East China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table East China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table East China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure East China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table Northeast China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table Northeast China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure Northeast China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table Northeast China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table Northeast China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table Southwest China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table Southwest China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure Southwest China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table Southwest China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table Southwest China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table Northwest China Medicine for Osteoarthritis Pain Production Volume by Type (2018-2023)

    • Table Northwest China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Figure Northwest China Medicine for Osteoarthritis Pain Production Volume Share by Type (2018-2023)

    • Table Northwest China Medicine for Osteoarthritis Pain Sales Volume by Application (2018-2023)

    • Table Northwest China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Medicine for Osteoarthritis Pain Sales Volume Share by Application (2018-2023)

    • Table Tide Pharmaceutical Company Profile

    • Table Tide Pharmaceutical Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Profile

    • Table Daiichi Sankyo Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Hengrui Pharmaceutical Company Profile

    • Table Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Iroko Pharmaceuticals Company Profile

    • Table Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Abiogen Pharma Company Profile

    • Table Abiogen Pharma Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table TEVA Company Profile

    • Table TEVA Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)

    • Table Horizon Pharma Company Profile

    • Table Horizon Pharma Medicine for Osteoarthritis Pain Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US